PFC

Phocas Financial Corp Portfolio holdings

AUM $721M Turnover 18.82%
1-Year Est. Return 63.77%
This Fund
S&P 500
This Quarter Est. Return
+29.34%
1 Year Est. Return
+63.77%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$721M
AUM Growth
+$83.9M
Cap. Flow
-$47.5M
Cap. Flow %
-6.59%
Top 10 Hldgs %
17.87%
Holding
170
New
15
Increased
11
Reduced
103
Closed
17
Avg Time Held
2.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
MUR icon
Murphy Oil
MUR
+$3.88M
2
MDU icon
MDU Resources
MDU
+$3.44M
3
UBSI icon
United Bankshares
UBSI
+$3.34M
4
FLG icon
Flagstar Bank National Association
FLG
+$3.31M
5
MCY icon
Mercury Insurance
MCY
+$3.31M

Top Sells

Rank Stock Value
1
TPH icon
Tri Pointe Homes
TPH
+$7.71M
2
PRIM icon
Primoris Services
PRIM
+$6.97M
3
SANM icon
Sanmina
SANM
+$6.62M
4
PTEN icon
Patterson-UTI
PTEN
+$6.46M
5
PENG icon
Penguin Solutions Inc
PENG
+$5.9M

Sector Composition

Rank Sector Weight
1 Financials 25.27%
2 Industrials 15.23%
3 Healthcare 11.47%
4 Technology 11.37%
5 Real Estate 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
LZB icon
101
La-Z-Boy
LZB
$1.19B
$3.22M 0.45%
80,161
-4,267
-5% -$154K
2020 Q3
23 quarters
GOOGL icon
102
Alphabet (Google) Class A
GOOGL
$4.25T
$3.05M 0.42%
8,524
– –
2020 Q4
22 quarters
MHO icon
103
M/I Homes
MHO
$3.12B
$3.03M 0.42%
18,865
-1,028
-5% -$138K
2025 Q3
3 quarters
FUL icon
104
H.B. Fuller
FUL
$2.71B
$2.81M 0.39%
48,140
-2,543
-5% -$156K
2022 Q2
16 quarters
SUPN icon
105
Supernus Pharmaceuticals
SUPN
$2.34B
$2.8M 0.39%
60,253
-3,160
-5% -$152K
2025 Q4
2 quarters
SCHX icon
106
Schwab US Large- Cap ETF
SCHX
$74.4B
$2.74M 0.38%
93,009
-2,985
-3% -$85.2K
2023 Q4
10 quarters
SR icon
107
Spire
SR
$4.72B
$2.66M 0.37%
34,000
-1,767
-5% -$152K
2025 Q4
2 quarters
CUZ icon
108
Cousins Properties
CUZ
$4.42B
$2.58M 0.36%
86,145
-4,576
-5% -$120K
2025 Q1
5 quarters
AAPL icon
109
Apple
AAPL
$5.01T
$2.52M 0.35%
8,706
-148
-2% -$42.3K
2013 Q2
52 quarters
NVDA icon
110
NVIDIA
NVDA
$5.34T
$2.49M 0.35%
12,430
-945
-7% -$194K
2021 Q2
20 quarters
NRIX icon
111
Nurix Therapeutics
NRIX
$2.59B
$2.42M 0.34%
+99,589
New +$1.7M
2026 Q2
0 quarters
JJSF icon
112
J&J Snack Foods
JJSF
$1.47B
$2.2M 0.3%
29,908
-1,555
-5% -$121K
2025 Q4
2 quarters
VCYT icon
113
Veracyte
VCYT
$3.5B
$2.19M 0.3%
37,297
-1,973
-5% -$82.7K
2024 Q4
6 quarters
CYTK icon
114
Cytokinetics
CYTK
$8.82B
$2.1M 0.29%
+24,634
New +$1.77M
2026 Q2
0 quarters
PTGX icon
115
Protagonist Therapeutics
PTGX
$8.82B
$2.01M 0.28%
+16,378
New +$1.71M
2026 Q2
0 quarters
ACAD icon
116
Acadia Pharmaceuticals
ACAD
$3.32B
$1.95M 0.27%
77,245
-4,102
-5% -$90.3K
2023 Q3
11 quarters
DNLI icon
117
Denali Therapeutics
DNLI
$2.86B
$1.83M 0.25%
+71,197
New +$1.46M
2026 Q2
0 quarters
IDYA icon
118
IDEAYA Biosciences
IDYA
$3.27B
$1.82M 0.25%
+48,822
New +$1.49M
2026 Q2
0 quarters
ETN icon
119
Eaton
ETN
$159B
$1.74M 0.24%
4,090
– –
2022 Q1
17 quarters
MIRM icon
120
Mirum Pharmaceuticals
MIRM
$5.19B
$1.71M 0.24%
+14,637
New +$1.47M
2026 Q2
0 quarters
MSFT icon
121
Microsoft
MSFT
$3.96T
$1.52M 0.21%
4,080
– –
2015 Q1
45 quarters
JNJ icon
122
Johnson & Johnson
JNJ
$612B
$1.38M 0.19%
5,449
-66
-1% -$15.4K
2023 Q4
10 quarters
ARQT icon
123
Arcutis Biotherapeutics
ARQT
$3.32B
$1.25M 0.17%
47,746
-2,553
-5% -$59.5K
2025 Q1
5 quarters
BRK.B icon
124
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.12M 0.16%
2,237
– –
2020 Q4
22 quarters
CSD icon
125
Invesco S&P Spin-Off ETF
CSD
$209M
$1.11M 0.15%
7,400
– –
2018 Q2
32 quarters
3 4
5
6 7

Similar funds

SFS
Security Financial Services Fort Wayne, Indiana $721M AUM 22.53% 1-Year Est. Return
SCM
Shenkman Capital Management New York $721M AUM 0.22% 1-Year Est. Return
DI
Deeter Investments Austin, Texas $721M AUM
ACM
ASK Capital Management San Francisco, California $721M AUM 36.53% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $721M AUM 13.67% 1-Year Est. Return
HS
Hazelview Securities Toronto, Ontario, Canada $722M AUM 19.65% 1-Year Est. Return
AO
Allen Operations New York $722M AUM 20.02% 1-Year Est. Return
BCV
Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return

Phocas Financial Corp's Q2 2026 Portfolio in Review

As of Q2 2026, Phocas Financial Corp held 170 positions worth $721M, up 13% from $637M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Phocas Financial Corp withdrew a net $47.5M in Q2 2026, closing 17 positions and reducing 103 holdings. Its most notable exit was Tri Pointe Homes, an estimated $7.71M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Phocas Financial Corp opened a new position in Murphy Oil worth $3.3M.

  • Phocas Financial Corp's largest Q2 2026 buy was Murphy Oil: 101,370 shares worth $3.3M.
  • Phocas Financial Corp added most to MDU Resources in Q2 2026, an estimated $3.44M increase.
  • Phocas Financial Corp's biggest Q2 2026 reduction was Sanmina, cutting an estimated $6.62M.
  • Phocas Financial Corp fully exited Tri Pointe Homes in Q2 2026, selling an estimated $7.71M.
  • Phocas Financial Corp's ten largest holdings make up 18% of its $721M portfolio in Q2 2026.
  • Phocas Financial Corp opened 15 new positions and closed 17 in Q2 2026.
  • Phocas Financial Corp's portfolio value rose 13% quarter-over-quarter to $721M.

Based on Phocas Financial Corp's 13F filing for Q2 2026, filed 31 Jul 2026.